Chugai Pharmaceutical Co (JP:4519) has released an update.
Chugai Pharmaceutical Co. has increased its full-year revenue and profit forecasts for 2024, citing stronger domestic and overseas sales, including higher exports to Roche. The company now expects revenue of ¥1,150.0 billion and core operating profit of ¥540.0 billion, both significantly up from previous estimates.
For further insights into JP:4519 stock, check out TipRanks’ Stock Analysis page.
